| human | Q5 |
| P269 | IdRef ID | 073349364 |
| P213 | ISNI | 0000000356806364 |
| P2798 | Loop ID | 381796 |
| P496 | ORCID iD | 0000-0003-1840-1817 |
| P3829 | Publons author ID | 2267384 |
| P1053 | ResearcherID | H-1674-2016 |
| P214 | VIAF ID | 192754100 |
| P185 | doctoral student | Guillaume Lefevre | Q57083045 |
| P735 | given name | David | Q18057751 |
| David | Q18057751 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q38010222 | 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review |
| Q56977789 | 35 SYSTEMIC INFLAMMATORY AND AUTOIMMUNE DISEASES (SAID) ASSOCIATED WITH MDS: A FRENCH MULTICENTER RETROSPECTIVE STUDY |
| Q56978352 | A Four-Year History of Pruriginous Erythroderma Leading to the Diagnosis of Idiopathic Hypereosinophilic Syndrome |
| Q36195456 | A French National Survey on Clotting Disorders in Mastocytosis |
| Q56977660 | A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease? |
| Q56978099 | A descriptive and prognostic study of systemic sclerosis-associated myopathies |
| Q37726667 | A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients |
| Q41435645 | A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension |
| Q56977833 | AB0614 Prognostic Factors of Functional Outcome in Systemic Sclerosis-Associated Interstitial Lung Disease |
| Q37499442 | ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases. |
| Q37856845 | Abdominal pain in a 22-year-old woman |
| Q55116370 | Abstracts from the 10th C1-inhibitor deficiency workshop. |
| Q43545216 | Active immunological profile is associated with systemic Sjögren's syndrome |
| Q56977804 | Actualités en allergologie : médecine interne |
| Q49990679 | Altered B lymphocyte homeostasis and functions in systemic sclerosis. |
| Q38839877 | Aminothiazoles: Hit to lead development to identify antileishmanial agents |
| Q35680148 | An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies |
| Q50524471 | Anticoagulation withdrawal in antiphospholipid syndrome: a retrospective matched-control study. |
| Q47398038 | Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients |
| Q56978104 | Aortic aneurysm in MAGIC syndrome successfully managed with combined anti-TNF- and stent grafting |
| Q41936333 | Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients |
| Q56977525 | Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry |
| Q36084831 | Association between systemic sclerosis and breast cancer: eight new cases and review of the literature |
| Q56978287 | Atteinte cardiaque de la maladie de Fabry |
| Q56978069 | Atteintes neuropsychiatriques au cours de la sclérodermie systémique |
| Q56978110 | Autologous Hematopoietic Stem Cell Transplant in Systemic Sclerosis: Quantitative High Resolution Computed Tomography of the Chest Scoring |
| Q19862843 | Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial |
| Q37627201 | B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis |
| Q56978114 | Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy |
| Q56977887 | Benefits of progestin contraception in non-allergic angioedema |
| Q38680179 | Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients |
| Q56977467 | Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome |
| Q56978245 | Bosentan for the treatment of scleroderma |
| Q37216376 | CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder |
| Q37404896 | Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients |
| Q39435825 | Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature |
| Q43730907 | Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. |
| Q56978208 | Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach |
| Q56978404 | Cirrhose biliaire primitive et sclérodermie systémique (syndrome de Reynolds): à propos de huit nouveaux cas. Apport de la biopsie des glandes salivaires accessoires |
| Q56977626 | Clinical characteristics and response to attack treatment with Berinert® of drug induced angioedema in the French Cohort COBRA |
| Q45019100 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease |
| Q54957551 | Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis. |
| Q47639668 | Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis. |
| Q58423136 | Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality |
| Q56978055 | Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus |
| Q56978272 | Compte rendu du symposium Pfizer : l'hypertension artérielle pulmonaire, la bête noire des maladies systémiques : de la sclérodermie systémique à la maladie de Rendu-Osler |
| Q51901068 | Consultation/liaison psychiatry practice: combined medical and psychiatric consultations. |
| Q38721897 | Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH). |
| Q46693450 | Cytokine concentrations in exhaled breath condensates in systemic sclerosis. |
| Q40384455 | Cytomegalovirus and systemic lupus: severe infection and difficult diagnosis |
| Q43658958 | DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases |
| Q40900327 | Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial |
| Q35008392 | Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents. |
| Q51749271 | Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs. |
| Q37689570 | Diagnosis and classification of systemic sclerosis |
| Q48878700 | Diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement. |
| Q40335052 | Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection |
| Q37605477 | Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases |
| Q43140263 | Disseminated Infection Caused by Francisella philomiragia, France, 2014. |
| Q41132442 | Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies |
| Q46059739 | Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist? |
| Q56978382 | Dépistage de l’hypertension artérielle pulmonaire au cours de la sclérodermie systémique : étude d’une cohorte de 67 patients |
| Q56977573 | Dépistage de l’hypertension pulmonaire au cours de la sclérodermie systémique : une stratégie optimale encore à définir |
| Q56978083 | Dépistage et diagnostic de l’hypertension artérielle pulmonaire. À propos des dernières recommandations des Sociétés Européennes de Cardiologie et de Pneumologie |
| Q56978308 | Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study |
| Q34635020 | Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome |
| Q43264966 | Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy |
| Q54503853 | Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review. |
| Q37003609 | Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study |
| Q56977454 | Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients |
| Q51412493 | Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. |
| Q56978237 | Entéropathie exsudative révélant une péricardite chronique constrictive idiopathique |
| Q52567183 | Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study. |
| Q56977600 | Extensive levamisole-induced vasculitis |
| Q56977968 | FRI0245 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the french registry |
| Q56977962 | FRI0254 Prognosis factors for survival and progression-free survival in systemic sclerosis–associated interstitial lung disease |
| Q56977708 | FRI0299 Pulmonary Arterial Hypertension in Idiopathic Inflammatory Myopathies: Data from The French Pulmonary Hypertension Registry and Review of The Literature |
| Q56977846 | FRI0479 Serum Free Light Chains of Immunoglobulins Are Associated with Disease Activity in Systemic Sclerosis: A Prospective and Controlled Study |
| Q56977734 | FRI0509 Chromosome 22Q11.2 Deletion Syndrome (Digeorge Syndrome) and Autoimmunity: A French Retrospective Pediatric Study of 15 Cases |
| Q40984438 | Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study |
| Q47151670 | Factors associated with the 6-minute walk distance in patients with systemic sclerosis. |
| Q53171432 | Gentle blood aspiration and tube cushioning reduce pneumatic tube system interference in lactate dehydrogenase assays. |
| Q43195998 | Graft-versus-host disease-related polymyositis |
| Q56977596 | Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis |
| Q56977551 | Haemodynamics and serial risk assessment in systemic-sclerosis associated pulmonary arterial hypertension |
| Q33399480 | Haemophagocytic syndrome in pregnancy: a case report |
| Q56978043 | Hallucinations visuelles et maladie de Horton : à propos du syndrome de Charles Bonnet |
| Q56977750 | Hereditary Angioedema: Clinical Characteristics and Treatment Response with Berinert in a French Cohort in Patient Under 16 Years Old |
| Q44594522 | Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients |
| Q44495008 | Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype |
| Q38857834 | Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema |
| Q29248157 | Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant |
| Q38934024 | Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort |
| Q56977484 | Hereditary angioedema: Clinical presentation and socioeconomic cost of 200 French patients |
| Q56978314 | High Throughput Physical Organic Chemistry: Analytical Constructs for Monomer Reactivity Profiling |
| Q54491866 | High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. |
| Q28283828 | High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome |
| Q56977982 | Hypertension artérielle pulmonaire et sclérodermie systémique : les pièges |
| Q45121500 | Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder |
| Q56978410 | Hématome périrénal spontané bilatéral: une complication rare de la panartérite noueuse |
| Q37038511 | Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature |
| Q46884569 | Iloprost for the treatment of systemic sclerosis |
| Q37748148 | Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease |
| Q45736006 | Immunological profiles determine neurological involvement in Sjögren's syndrome. |
| Q56978175 | Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases |
| Q45985571 | In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis. |
| Q40518515 | Inflammatory aortitis |
| Q36193594 | Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases |
| Q56978399 | Influence de l'âge sur les caractéristiques cliniques et biologiques de la sclérodermie systémique |
| Q56978143 | Innovation thérapeutique pour le traitement de l’angiœdème héréditaire : Firazyr® (icatibant) – 58e congrès national de médecine interne. Bordeaux, 12 décembre 2008 |
| Q56977779 | Interactions pharmacovigilance – service de médecine interne : une aide précieuse au diagnostic |
| Q31165345 | Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature. |
| Q56977653 | Intérêt de la médecine nucléaire dans la maladie d’Erdheim-Chester : une expérience lilloise |
| Q56978188 | Intérêt du dosage plasmatique de l'endothéline au cours de la sclérodermie systémique |
| Q56978063 | Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis? |
| Q51131925 | Is pulmonary arterial hypertension really a late complication of systemic sclerosis? |
| Q56978340 | Large granular lymphocyte leukaemia associated with systemic sclerosis |
| Q56978257 | Le bosentan dans le traitement des ulcères digitaux évolutifs au cours de la sclérodermie systémique (9 cas) |
| Q56978127 | Le syndrome de Means : à propos d’une observation |
| Q56978281 | Letter to the Editor |
| Q47673957 | Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing |
| Q40191096 | Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study |
| Q43218254 | Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil |
| Q38229870 | Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group |
| Q56978161 | Maladie de Still de l’adulte et angiosarcome hépatique, une association fortuite ou un syndrome paranéoplasique : à propos d’un cas |
| Q56978251 | Maladie de Takayasu |
| Q56978260 | Maladie kystique pulmonaire compliquant le syndrome de Gougerot-Sjögren : deux observations |
| Q51828286 | Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. |
| Q34219627 | Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey |
| Q33433126 | Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients |
| Q56978221 | Micropolyangéite révélée par une anémie d'évolution chronique secondaire à une hémorragie intra-alvéolaire paucisymptomatique: à propos d'un cas |
| Q56977697 | Midostaurin in Advanced Systemic Mastocytosis |
| Q44845017 | Mixed connective tissue disease presenting as trigeminal neuropathy |
| Q42931182 | Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. |
| Q48560986 | N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis |
| Q56977951 | Neurolupus (1re partie). Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémique |
| Q56977955 | Neurolupus (2e partie). Description des outils diagnostiques et thérapeutiques devant une manifestation psychiatrique ou neurologique centrale au cours du lupus érythémateux systémique |
| Q36822636 | Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review |
| Q35412114 | Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis |
| Q49713667 | No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases |
| Q56977612 | Normal PAI-2 level in French FXII-HAE patients |
| Q56977770 | OP0059 Phenotypes Determined by Cluster Analysis and their Survival in the Prospective Eustar Cohort of Patients with Systemic Sclerosis |
| Q56977621 | OP0236 Benefit and safety of antithrombotic treatment in 264 pregnancies in patients with antiphospholipid syndrome |
| Q56978198 | Occlusion de l'artère centrale de la rétine au cours de la granulomatose de Wegener |
| Q43575009 | Osteolytic lesion with thick sclerotic walls and demyelinating polyneuropathy |
| Q56978228 | Periorbital Ecchymoses Are Not Pathognomonic of the Light-chain Type of Amyloidosis |
| Q51314663 | Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity. |
| Q56978193 | Place du bosentan dans le traitement de l'hypertension artérielle pulmonaire de la sclérodermie systémique |
| Q56977998 | Plaintes et besoins des patients atteints de sclérodermie systémique : une meilleure connaissance afin d’améliorer le suivi |
| Q56977495 | Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: Three additional French families |
| Q43235342 | Pneumatic transport is critical for leukaemic patients with major leukocytosis: what precautions to measure lactate dehydrogenase, potassium and aspartate aminotransferase? |
| Q56978010 | Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: prevalence, risk factors of colonization and outcome |
| Q46886236 | Polymyositis and cranial neuropathy |
| Q56977917 | Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey |
| Q38177959 | Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey. |
| Q38649246 | Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease |
| Q56978366 | Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome |
| Q27000819 | Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis |
| Q51694730 | Primary Sjogren's syndrome in men. |
| Q56977909 | Prise en charge des angiœdèmes induits par les inhibiteurs de l’enzyme de conversion de l’angiotensine : recommandations du Centre de référence national des angiœdèmes |
| Q56978077 | Prognosis Assessment of Cardiac Involvement in Systemic AL Amyloidosis by Magnetic Resonance Imaging |
| Q34268941 | Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. |
| Q47108737 | Proinflammatory B-cell profile in the early phases of MS predicts an active disease |
| Q33426263 | Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome |
| Q50278619 | Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry |
| Q46425996 | Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome |
| Q30245016 | Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature |
| Q36943691 | Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature |
| Q53121309 | Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. |
| Q49713250 | Pulmonary hypertension in systemic sclerosis: different phenotypes |
| Q37824943 | Pulmonary manifestations of Sjögren's syndrome |
| Q56977873 | Quel bilan pour quelle mastocytose ? |
| Q38157393 | Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health. |
| Q40480177 | Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. |
| Q33436010 | Reemergence of Splenectomy for ITP Second-line Treatment? |
| Q35035897 | Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis |
| Q56977534 | Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab |
| Q34004145 | Renal extramedullary hematopoiesis |
| Q56977542 | Reply to Gilchrist et al. and to Musher |
| Q39521874 | Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis. |
| Q37100627 | Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study |
| Q33757203 | Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab |
| Q45855470 | Rituximab in postpartum-related acquired hemophilia |
| Q39884656 | Role of B cells in the pathogenesis of systemic sclerosis |
| Q47957345 | Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis |
| Q51511625 | Role of iconographic examinations in the treatment algorithm in Erdheim-Chester disease. |
| Q56977763 | SAT0543 Igg4-Related Disease: Clinical and Biological Characteristics in 90 Patients from a Large Multicentric National Registry |
| Q33673139 | Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry |
| Q56978373 | Sausage-like toe and heel pain: value for diagnosing and evaluating the severity of spondyloarthropathies defined by Amor's criteria. A retrospective study in 161 patients |
| Q56977460 | Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology |
| Q56977976 | Scleroderma Lung Disease |
| Q56978388 | Scleromyxedema (lichen myxedematosus) associated with dermatomyositis |
| Q56977585 | Sclérodermie systémique et difficultés professionnelles : résultats d’une enquête prospective |
| Q56978019 | Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival |
| Q33395411 | Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party |
| Q56977794 | Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients |
| Q56977854 | Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity |
| Q56978089 | Soixantième Congrès de la Société Nationale Française de Médecine Interne & quatrième Congrès Franco-Maghrébin de Médecine Interne (Toulouse, 9-12 décembre 2009) : les temps forts |
| Q30244385 | Special considerations in pregnant systemic sclerosis patients |
| Q56977519 | Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial |
| Q40263858 | Specific polysaccharide antibody deficiency revealed by severe bacterial infections in adulthood: a report on eleven cases |
| Q35741844 | Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. |
| Q40268126 | Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies |
| Q43251307 | Superficial cranial venous thromboses preceding the diagnosis of giant cell arteritis |
| Q38112387 | Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. |
| Q37345940 | Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era. |
| Q56978322 | Syndrome de Gougerot-Sjögren et pupille tonique d’Adie |
| Q56978417 | Syndrome des ongles jaunes associé à une polyarthrite rhumatoïde. Régression sous chrysothérapie |
| Q48949805 | Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study |
| Q46350918 | Systemic sclerosis and pregnancy |
| Q38242732 | Systemic sclerosis and prevalence of monoclonal immunoglobulin |
| Q56978031 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies |
| Q42364525 | TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature. |
| Q34447936 | The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype |
| Q56978037 | Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients |
| Q38162278 | To spare or not to spare…? The aortic valve in scleroderma and aortic root aneurysm |
| Q56977642 | Tolérance du bévacizumab au cours de l’hypertension artérielle pulmonaire associée à la sclérodermie systémique : à propos d’une observation |
| Q56977992 | Tout part de Greenwich… |
| Q56977757 | Traitements des angiœdèmes héréditaires : recommandations du centre de référence national des angiœdèmes (consensus 2014 de Bordeaux) |
| Q56977866 | Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients |
| Q56978346 | Un vrai micmac! |
| Q56978292 | Une amylose qui déclone |
| Q56978358 | Une association rare : péliose hépatique et maladie de Crohn |
| Q56977934 | Une atteinte du trijumeau révélatrice d’un syndrome de Sharp |
| Q56977880 | Une gastrite atypique |
| Q35759176 | Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population |
| Q50075629 | Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies. |
| Q56977476 | Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis |
| Q53545569 | [18FDG PET: a new criterion for disease activity in Takayasu arteritis]. |
| Q55034157 | [Agranulocytosis connected with the taking of mianserin: a complication to be feared in the aged]. |
| Q53655119 | [Angioedema: differential diagnosis]. |
| Q53370282 | [Dyspnea upon exertion in systemic scleroderma: from symptom to etiological diagnosis]. |
| Q54080501 | [Hemorrhagic shock revealing multiple digestive microaneurysms in a patient with systemic lupus erythematosus: Case report and literature review]. |
| Q54447724 | [Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or colonisation?]. |
| Q50794063 | [Pulmonary arterial hypertension and systemic sclerosis]. |
| Q56978132 | Échographie et Doppler fœtaux dans le bloc auriculoventriculaire congénital d’origine immunologique |
| Q56978335 | Étude de l'influence d'une hypergammaglobulinémie sur le titre des anticorps antiphospholipides |
| Q56978299 | Étude de la fonction cardiopulmonaire avant et après traitement par cyclophosphamide dans la sclérodermie systémique sévère : comparaison de deux modes d'administration |
| Q57083045 | Guillaume Lefevre | doctoral advisor | P184 |
Search more.